📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
5
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
20%
📉 Score Deterioration
25%
• Score increased 10 points recently (worsening)
💰 Capital Raise
18%
• Active ATM program with $205M remaining capacity
📜 Warrant Exercise
15%
• Warrant overhang: 7.1% of shares outstanding
💹 Market Data
Market Cap$772.30M
Shares Outstanding103.39M
Float93.38M
Cash$114.73M
Debt$16.99M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 3.1% shares (2025Q4 vs prior)
117 institutional holders · 50.34M shares
#1
Matrix Capital Management Company, LP
6.92M shares
#2
Frazier Life Sciences Management, L.P.
5.10M shares
#3
ADAGE CAPITAL PARTNERS GP, L.L.C.
4.88M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest3.16M
Days to Cover2.8
% of Float3.4%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
424B5
ATM
May 05, 2026
424B5
ATM
May 04, 2026
8-K
8K EVENT
May 04, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for AURA
📊 AURA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 AURA Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.